Curated dataset · n=61 verified deals · Not live market data · Scores are descriptive, not forecasts.
You are here

Deals — Network graph, deal flow, valuation matrix, and acquirer landscape.

Smith & Nephew Gynecology (Truclear)
→
Medtronic

Acquisition · Cash · MDT · announced May 18, 2016

View in network
  1. Announced

    May 18, 2016

  2. Closed

    Aug 8, 2016

Economics

Cash()

Pre-deal · pre-deal mark: 2016, year precision · Medtronic 8-K filing, SEC EDGAR — Truclear acquisition

$350M divestiture price (Smith & Nephew press release)

Target

Smith & Nephew Gynecology (Truclear)

Gynecological Surgery · Clinical / therapeutic

HQ London, UK

TRUCLEAR hysteroscopic tissue resection system for minimally invasive treatment of abnormal uterine bleeding — polyps and fibroids; $56M annual revenue at divestiture

  • Smith & Nephew press release (May 18, 2016)
  • Medtronic press release (May 18, 2016)
  • MassDevice deal coverage (Aug 8, 2016 — close confirmed)

Acquirer

Medtronic (MDT)

Gynecological Surgery

HQ Dublin, Ireland

Why this buyer

Curated copy from the verified dataset — not an 8-K LLM summary

TRUCLEAR hysteroscopic system expands minimally invasive GYN portfolio — targets abnormal uterine bleeding (polyps/fibroids) with $56M trailing revenue

Evidence ladder

Press only — no primary filingValue disclosed
  1. Secondary (press / IR)

    Medtronic press release (May 18, 2016)

  2. Secondary (press / IR)

    Smith & Nephew press release (Aug 8, 2016 — close confirmation)

Limitations

  • Citations are press/IR only — two wires of the same announcement are not dual-source. Add a primary filing.
  • $350M divestiture price (Smith & Nephew press release)
  • Pre-deal valuation sourced from: Medtronic 8-K filing, SEC EDGAR — Truclear acquisition. Pre-deal market-cap and funding citations do not corroborate the acquisition.

Valuation peers · Gynecological Surgery

Same sector, same deal type, announced within ±3 years, disclosed value within 0.25×–4× of this transaction. Ranked by evidence class, then same acquirer, until you sort.

Insufficient disclosed data

No verified Gynecological Surgery deals meet the peer rule: same deal type, announced within ±3 years, and a disclosed value inside 0.25×–4× of this transaction.

Other verified deals by Medtronic

Acquirer program history not already listed as a valuation peer or adjacency row.

No further verified deals

Other verified transactions by Medtronic are already listed above, or none are in the dataset.

Patient empowerment context

Patient empowerment baseline (HLTH 2022)

No curated mapping — Smith & Nephew Gynecology (Truclear) (Gynecological Surgery). HLTH/Outcomes4Me 2022 baseline is Breast cancer care continuum (HLTH 2022). No curated mapping for this target in the verified crosswalk.

Research workspace (includes heuristic crosswalk) →

Related verified workspaces

Lacuna is a curated public-source sample, not a census of women's-health M&A. Coverage varies by sector, geography, disclosure availability, and women's-health scope. Undisclosed transaction values are excluded from disclosed-value totals.

Curated verified dataset v11 · updated 2026-10-19 · 2 citations on this deal · Data compiled from public sources for educational visualization. Verify independently before any commercial use.